96 related articles for article (PubMed ID: 21293001)
1. Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling.
Costandi J; Melone M; Zhao A; Rashid S
Circ Res; 2011 Mar; 108(6):727-42. PubMed ID: 21293001
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
3. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
Qin B; Dawson H; Anderson RA
Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
[TBL] [Abstract][Full Text] [Related]
4. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
5. Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver.
Aspichueta P; Pérez-Agote B; Pérez S; Ochoa B; Fresnedo O
J Endotoxin Res; 2006; 12(3):181-92. PubMed ID: 16719989
[TBL] [Abstract][Full Text] [Related]
6. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
7. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
Jin UH; Kang YJ; Chang YC; Kim CH
J Cell Biochem; 2008 Feb; 103(3):908-19. PubMed ID: 17647275
[TBL] [Abstract][Full Text] [Related]
8. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes.
Vergès B
Atherosclerosis; 2010 Aug; 211(2):353-60. PubMed ID: 20189175
[TBL] [Abstract][Full Text] [Related]
9. Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat.
Frick F; Lindén D; Améen C; Edén S; Mode A; Oscarsson J
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1023-31. PubMed ID: 12376331
[TBL] [Abstract][Full Text] [Related]
10. A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice.
Huynh FK; Neumann UH; Wang Y; Rodrigues B; Kieffer TJ; Covey SD
Hepatology; 2013 Feb; 57(2):543-54. PubMed ID: 22941940
[TBL] [Abstract][Full Text] [Related]
11. Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN; Zhang YL; Hernandez-Ono A
Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
[TBL] [Abstract][Full Text] [Related]
12. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
13. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
[TBL] [Abstract][Full Text] [Related]
14. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.
Sparks JD; Sparks CE; Adeli K
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2104-12. PubMed ID: 22796579
[TBL] [Abstract][Full Text] [Related]
15. Lipid and lipoprotein dysregulation in insulin resistant states.
Avramoglu RK; Basciano H; Adeli K
Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation.
Kuriyama H; Yamashita S; Shimomura I; Funahashi T; Ishigami M; Aragane K; Miyaoka K; Nakamura T; Takemura K; Man Z; Toide K; Nakayama N; Fukuda Y; Lin MC; Wetterau JR; Matsuzawa Y
Hepatology; 1998 Feb; 27(2):557-62. PubMed ID: 9462657
[TBL] [Abstract][Full Text] [Related]
17. Translational control of apolipoprotein B mRNA via insulin and the protein kinase C signaling cascades: evidence for modulation of RNA-protein interactions at the 5'UTR.
Sidiropoulos KG; Zastepa A; Adeli K
Arch Biochem Biophys; 2007 Mar; 459(1):10-9. PubMed ID: 17288985
[TBL] [Abstract][Full Text] [Related]
18. Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture.
Lin Y; Havinga R; Verkade HJ; Moshage H; Slooff MJ; Vonk RJ; Kuipers F
Hepatology; 1996 Feb; 23(2):218-28. PubMed ID: 8591844
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes.
De Gottardi A; Spahr L; Ravier-Dall'Antonia F; Hadengue A
Liver Int; 2010 Nov; 30(10):1482-9. PubMed ID: 20602678
[TBL] [Abstract][Full Text] [Related]
20. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids.
Guo Q; Avramoglu RK; Adeli K
Metabolism; 2005 May; 54(5):689-97. PubMed ID: 15877301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
